Similar articles

• [Statement on the diagnosis and treatment of tobacco dependence in patients with cardiovascular diseases].

  Zatoński W, Jankowski P, Banasiak W, Kawecka-Jaszcz K, Musiał J, Narkiewicz K, Opolski G, Podolec P, Torbicki A, Zembala M. Zatoński W, et al. Kardiol Pol. 2011;69(1):96-100. Kardiol Pol. 2011. PMID: 21267983 Polish. No abstract available.
• Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit.

  Jiménez-Ruiz CA, Andreas S, Lewis KE, Tonnesen P, van Schayck CP, Hajek P, Tonstad S, Dautzenberg B, Fletcher M, Masefield S, Powell P, Hering T, Nardini S, Tonia T, Gratziou C. Jiménez-Ruiz CA, et al. Eur Respir J. 2015 Jul;46(1):61-79. doi: 10.1183/09031936.00092614. Epub 2015 Apr 16. Eur Respir J. 2015. PMID: 25882805 Review.
• Review of bupropion for smoking cessation.

  Richmond R, Zwar N. Richmond R, et al. Drug Alcohol Rev. 2003 Jun;22(2):203-20. doi: 10.1080/09595230100100642. Drug Alcohol Rev. 2003. PMID: 12850907 Review.
• Smoking cessation programs and other preventive strategies for chronic obstructive pulmonary disease.

  Kumar R, Vijayan VK. Kumar R, et al. J Assoc Physicians India. 2012 Feb;60 Suppl:53-6. J Assoc Physicians India. 2012. PMID: 23155814 No abstract available.
• A Retrospective Analysis of the Outcomes of Smoking Cessation Pharmacotherapy Among Persons With Mental Health and Substance Use Disorders.

  Okoli CT, Anand V, Khara M. Okoli CT, et al. J Dual Diagn. 2017 Jan-Mar;13(1):21-28. doi: 10.1080/15504263.2017.1290860. Epub 2017 Feb 6. J Dual Diagn. 2017. PMID: 28166473